BCM
BML Capital Management Portfolio holdings
AUM
$131M
This Quarter Return
+14.7%
1 Year Return
+89.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$131M
AUM Growth
+$131M
(+5.6%)
Cap. Flow
-$2.48M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
87.77%
Holding
29
New
1
Increased
10
Reduced
3
Closed
5
Top Buys
| 1 |
ALMS
Alumis Inc. Common Stock
ALMS
|
$3.48M |
| 2 |
Instil Bio
TIL
|
$2.46M |
| 3 |
PMV Pharmaceuticals
PMVP
|
$1.33M |
| 4 |
Kezar Life Sciences
KZR
|
$1.04M |
| 5 |
Adverum Biotechnologies
ADVM
|
$678K |
Top Sells
| 1 |
AN2 Therapeutics
ANTX
|
$7.82M |
| 2 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$3.36M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$1.07M |
| 4 |
CNTB
Connect Biopharma
CNTB
|
$266K |
| 5 |
NextCure
NXTC
|
$131K |
Sector Composition
| 1 | Healthcare | 99.02% |
| 2 | Technology | 0.98% |
| 3 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Atea Pharmaceuticals
AVIR
$267M
| $27.4M | 20.73% | 7,609,812 | – | – |
|
|
THRD
2
DELISTED
Third Harmonic Bio
THRD
| $20.8M | 15.71% | 3,824,417 | – | – |
|
3
Aclaris Therapeutics
ACRS
$209M
| $20.2M | 15.31% | 14,250,000 | – | – |
|
|
4
Instil Bio
TIL
$182M
| $11.1M | 8.43% | 534,899 +118,179 | +28% | +$2.46M |
|
5
ESSA Pharma
EPIX
$11.4M
| $7.18M | 5.43% | 4,221,546 | – | – |
|
6
Oramed Pharmaceuticals
ORMP
$90.2M
| $6.94M | 5.25% | 3,083,253 +62,505 | +2% | +$141K |
|
|
7
Adverum Biotechnologies
ADVM
$64.6M
| $6.57M | 4.97% | 3,057,526 +315,209 | +11% | +$678K |
|
|
IMA
8
ImageneBio, Inc. Common Stock
IMA
$150M
| $5.4M | 4.09% | 4,030,102 +319,299 | +9% | +$428K |
|
|
9
PMV Pharmaceuticals
PMVP
$74.2M
| $5.3M | 4.01% | 5,000,000 +1,252,388 | +33% | +$1.33M |
|
|
ALMS
10
Alumis Inc. Common Stock
ALMS
$479M
| $3.63M | 2.75% | 1,210,415 +1,160,788 | +2,339% | +$3.48M |
|
|
11
Kezar Life Sciences
KZR
$28.9M
| $2.91M | 2.2% | 635,183 +227,045 | +56% | +$1.04M |
|
12
LAVA Therapeutics
LVTX
$41.3M
| $2.6M | 1.97% | 1,970,610 +10,000 | +0.5% | +$13.2K |
|
13
Milestone Pharmaceuticals
MIST
$156M
| $2.2M | 1.67% | 1,136,091 | – | – |
|
|
ELEV
14
DELISTED
Elevation Oncology
ELEV
| $2.16M | 1.64% | 5,890,434 -500 | -0% | -$184 |
|
|
CNTB
15
Connect Biopharma
CNTB
$115M
| $1.79M | 1.35% | 1,821,558 -271,674 | -13% | -$266K |
|
16
Astrotech Corp
ASTC
$8.72M
| $1.27M | 0.96% | 220,410 | – | – |
|
17
Athira Pharma
ATHA
$15.3M
| $976K | 0.74% | 3,230,667 +30,000 | +0.9% | +$9.06K |
|
18
Lisata Therapeutics
LSTA
$19.9M
| $608K | 0.46% | 209,814 -7,039 | -3% | -$20.4K |
|
19
Corvus Pharmaceuticals
CRVS
$428M
| $475K | 0.36% | +118,766 | New | +$475K |
|
|
TSBX
20
DELISTED
Turnstone Biologics
TSBX
| $396K | 0.3% | 1,103,386 | – | – |
|
21
VistaGen Therapeutics
VTGN
$102M
| $300K | 0.23% | 150,000 | – | – |
|
22
HilleVax
HLVX
$105M
| $183K | 0.14% | 91,913 +71,153 | +343% | +$142K |
|
23
Verrica Pharmaceuticals
VRCA
$52.8M
| $92.6K | 0.07% | 174,651 | – | – |
|
|
24
AN2 Therapeutics
ANTX
$30.1M
| – | – | -5,749,432 | Closed | -$7.82M |
|
|
25
NextCure
NXTC
$13.5M
| – | – | -273,536 | Closed | -$131K |
|